Antigen Testing: How Rapid Results Improve Patient Outcomes

Title: Antigen Testing: How Rapid Results Improve Patient Outcomes
Date: September 12, 2024
Time: 12 p.m. ET
Presenter: Stephen Young, PhD, D(ABMM), Medical Director, Research and Clinical Trials Department at TriCore Research Institute

Make Better Decisions at the Point of Care
In this webinar, you’ll learn how gaining rapid results from antigen testing at the point of care plays a pivotal role in guiding treatment and management decisions in urgent care and other outpatient clinical settings. Take a look back at lessons learned from the 2023 respiratory illness season to highlight specific steps that healthcare providers can take now to be better prepared for the 2024–2025 season. In addition, an overview of molecular and antigen tests will provide insights into the contrasts and advantages of the two testing methods.
Learning Objectives
This webinar will help you:
- Verify why testing is critical at the point of care
- Prepare for respiratory illness season by reviewing previous events
- Evaluate the advantages of rapid antigen tests during respiratory illness season
- Clarify the differences between molecular and antigen tests and assess the benefits of each
Watch on Demand Download Slides (PDF, 1.5 MB)
Fisher Healthcare is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.™ Program. One P.A.C.E.™ credit-hour will be provided for this complimentary basic level program.
Presenter

Stephen Young, PhD, D(ABMM), Medical Director, Research and Clinical Trials Department at TriCore Research Institute
Dr. Stephen Young is currently the principal investigator for 40 FDA clinical trials, primarily for SARS-CoV-2 Emergency Use Authorization detection assays. Prior to becoming a medical director at TriCore Research Institute, he was the scientific director of the infectious disease section at TriCore Reference Laboratories for 17 years.
He received his bachelor’s and master’s degrees in Biological Sciences from Wright State University and his PhD from the University of New Mexico (UNM). He completed an American Board of Medical Microbiology (ABMM) post-doctoral fellowship program at the University of Washington. Dr. Young has been a diplomat of ABMM for the last 21 years and is a fellow of the American Association for the Advancement of Science. He is an emeritus professor in Pathology at UNM.